Related Experiment Video
Updated: Apr 5, 2026

10:10
Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
Published on: February 15, 2022
2.0K
A nanopore membrane regulator device for laser modulated flow after glaucoma surgery
Jeffrey L Olson1, Ramanath Bhandari, Sergio Groman-Lupa
1Rocky Mountain Lions Eye Institute, University of Colorado School of Medicine, 1675 Aurora Court, Aurora, CO, 80045, USA, jeffrey.olson@ucdenver.edu.
Biomedical Microdevices
|August 15, 2015
Summary
New glaucoma drainage device implants offer adjustable control of intraocular pressure (IOP) after surgery. This innovation aims to reduce complications like over- or under-filtration, improving patient outcomes.
Area of Science:
- Ophthalmology
- Biomedical Engineering
Background:
- Glaucoma is a leading cause of blindness globally, with elevated intraocular pressure (IOP) as a key risk factor.
- Filtration surgery effectively lowers IOP but carries risks of over- or under-filtration, leading to complications.
- Current treatments often fail to provide adequate post-operative IOP management.
Purpose of the Study:
- To introduce and evaluate the glaucoma drainage device regulator (GDDR) for adjustable post-operative IOP control.
- To mitigate complications associated with conventional glaucoma filtration surgeries.
Main Methods:
- Development of a novel glaucoma drainage device featuring a nanopore membrane.
- Surgical implantation of the GDDR beneath the scleral flap.
- Post-operative laser treatment to rupture the membrane and modulate aqueous flow.
Main Results:
- The GDDR allows for adjustable control of aqueous humor outflow post-surgery.
- Laser-induced membrane rupture enables augmentation of filtration flow when needed.
- The device design aims to reduce the incidence of early post-operative hypotony.
Conclusions:
- The GDDR implant offers a promising solution for managing post-operative IOP in glaucoma surgery.
- Adjustable flow control via the nanopore membrane enhances surgical safety and efficacy.
- This technology has the potential to improve long-term outcomes for glaucoma patients undergoing filtration surgery.
More Related Videos
Related Concept Videos
Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Angle Closure Glaucoma: Treatment
1.7K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.7K

